Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.39% |
| 2 | Financials | 6.67% |
| 3 | Healthcare | 6.18% |
| 4 | Industrials | 4.97% |
| 5 | Consumer Discretionary | 4.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3551
Replimune Group
REPL
$1.03B
| $2.62M | ﹤0.01% |
88,432
-31,152
| -26% | -$1.01M |
|
|
MON
3552
DELISTED
Monument Circle Acquisition Corp. Class A Common Stock
MON
| $2.62M | ﹤0.01% |
268,525
+110,000
| +69% | +$1.07M |
|
3553
PUT
Icon
ICLR
$12.3B
| $2.62M | ﹤0.01% |
10,000
+8,800
| +733% | +$2.14M |
|
3554
Marqeta
MQ
$1.9B
| $2.62M | ﹤0.01% |
29,613
-74,102
| -71% | -$7.93M |
|
|
FITB
3555
PUT
Fifth Third Bancorp
FITB
$51.7B
| $2.62M | ﹤0.01% |
61,700
+20,600
| +50% | +$789K |
|
3556
Acco Brands
ACCO
$399M
| $2.62M | ﹤0.01% |
304,705
-746,713
| -71% | -$6.58M |
|
3557
PUT
CONMED
CNMD
$1.54B
| $2.62M | ﹤0.01% |
20,000
+10,000
| +100% | +$1.31M |
|
3558
Shake Shack
SHAK
$2.6B
| $2.62M | ﹤0.01% |
+33,348
| New | +$3.03M |
|
3559
Liquidia Corp
LQDA
$7.44B
| $2.61M | ﹤0.01% |
947,039
-162,685
| -15% | -$423K |
|
|
ASLN
3560
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
| $2.61M | ﹤0.01% |
36,705
+2,973
| +9% | +$338K |
|
|
CLVS
3561
DELISTED
Clovis Oncology, Inc.
CLVS
| $2.6M | ﹤0.01% |
584,173
-1,720,201
| -75% | -$8.29M |
|
|
ISEE
3562
CALL
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $2.6M | ﹤0.01% |
+160,000
| New | +$1.74M |
|
|
TRONU
3563
DELISTED
Corner Growth Acquisition Corp. 2 Units
TRONU
| $2.6M | ﹤0.01% |
256,495
+5,705
| +2% | +$57.3K |
|
|
RC
3564
Ready Capital
RC
$276M
| $2.6M | ﹤0.01% |
179,961
+145,204
| +418% | +$2.2M |
|
|
IRAA
3565
DELISTED
Iris Acquisition Corp Class A Common Stock
IRAA
| $2.6M | ﹤0.01% |
267,397
-21,673
| -7% | -$210K |
|
|
BTRSW
3566
CALL
DELISTED
BTRS Holdings Inc. Warrants
BTRSW
| $2.59M | ﹤0.01% |
990,050
+606,300
| +158% | +$1.94M |
|
3567
Kiniksa Pharmaceuticals
KNSA
$5.75B
| $2.59M | ﹤0.01% |
227,515
-220,695
| -49% | -$2.87M |
|
3568
PUT
BlackSky Technology
BKSY
$962M
| $2.59M | ﹤0.01% |
+31,250
| New | +$2.56M |
|
3569
eHealth
EHTH
$44.8M
| $2.59M | ﹤0.01% |
63,899
+44,578
| +231% | +$2.08M |
|
|
BLU
3570
CALL
DELISTED
BELLUS Health Inc.
BLU
| $2.58M | ﹤0.01% |
+420,000
| New | +$1.59M |
|
|
ABX
3571
Abacus Global Management
ABX
$1.02B
| $2.58M | ﹤0.01% |
261,784
+225,000
| +612% | +$2.2M |
|
|
WEBR
3572
DELISTED
Weber Inc.
WEBR
| $2.58M | ﹤0.01% |
+146,372
| New | +$2.35M |
|
3573
iShares S&P 500 Growth ETF
IVW
$75.6B
| $2.57M | ﹤0.01% |
34,810
-9,170
| -21% | -$699K |
|
3574
JPMorgan Ultra-Short Income ETF
JPST
$40.3B
| $2.57M | ﹤0.01% |
50,649
-135,012
| -73% | -$6.85M |
|
3575
CALL
Phillips 66
PSX
$82.7B
| $2.56M | ﹤0.01% |
36,600
+200
| +0.5% | +$14.5K |
|
Similar funds
Millennium Management's Q3 2021 Portfolio in Review
As of Q3 2021, Millennium Management held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management deployed $8.65B of net new capital in Q3 2021, opening 1,244 new positions and adding to 2,720 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 7.8% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Millennium Management's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Millennium Management's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Millennium Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Millennium Management's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Millennium Management opened 1,244 new positions and closed 981 in Q3 2021.
- Millennium Management's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.